Anzeige
Mehr »
Login
Donnerstag, 06.05.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Breaking News bei Aktienchance: Alzheimer-Medikation!? Eine neue große Antwort?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCQ0 ISIN: CA4196211078 Ticker-Symbol: 5NP 
Tradegate
06.05.21
10:59 Uhr
0,500 Euro
+0,005
+1,01 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HAVN LIFE SCIENCES INC Chart 1 Jahr
5-Tage-Chart
HAVN LIFE SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,4830,49911:00
0,4910,50011:00
ACCESSWIRE
572 Leser
Artikel bewerten:
(2)

Havn Life Sciences Inc.: Havn Life Sciences to Host Investor Webcast on March 3, 2021

Attendees will have the opportunity to get the latest updates and participate in Q & A with Havn Life's CEO Tim Moore

VANCOUVER, BC / ACCESSWIRE / February 26, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, announced today that it will host a webcast investor presentation on Wednesday, March 3, at 2:00 p.m. EST (11:00 a.m. PST).

During the webcast, CEO Tim Moore will lead a PowerPoint presentation that will cover key areas of Havn Life's business plan. He'll be outlining the company's road map for 2021, sharing significant updates on Havn Labs and Havn Retail, discussing the launch of the retail product line this year, as well as key partnerships and financing benchmarks for the coming quarter. The webcast is a unique opportunity for current and potential investors to have direct access to Havn Life's CEO through an interactive Q & A portal and find out more about the company and its milestones.

WHO: Tim Moore, Havn Life Sciences - CEO

WHEN: Wednesday, March 3, at 2:00 p.m. EST

WHERE: To access to the webcast and ask questions during the live event, please pre-register using this link:

https://event.webcasts.com/starthere.jsp?ei=1429769&tp_key=deaceae0bb

An archived version of the webcast and presentation will be available using the same link or on the investor relations section of the Company's website.

On Behalf of The Board of Directors
Tim Moore
Chief Executive Officer

About Havn Life Sciences Inc.
Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The Company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram, and Youtube

Contact:
Investor Relations: ir@havnlife.com, 604 687 7130
Media: savi@emergence-creative.com, 647 896-8078

Cautionary Note Regarding Forward-Looking Statements
Certain statements contained in this news release, including statements which may contain words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", or similar expressions, and statements related to matters which are not historical facts, such as statements regarding the contemplated completion of the Acquisition, are forward-looking information within the meaning of applicable securities laws. Such forward-looking statements reflect management's expectations and are based on certain factors and assumptions and involve known and unknown risks and uncertainties which may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by such forward-looking statements. These factors should be considered carefully, and readers should not place undue reliance on the Company's forward-looking statements. The Company believes that the expectations reflected in the forward-looking statements contained in this news release are reasonable, but no assurance can be given that these expectations will prove to be correct, nor that the Acquisition will be completed as contemplated, or at all. The Company undertakes no obligation to release publicly any future revisions to forward-looking statements to reflect events or circumstances after the date of this news or to reflect the occurrence of unanticipated events, except as expressly required by law.

The CSE has not reviewed, approved or disapproved the content of this press release

SOURCE: Havn Life Sciences Inc.



View source version on accesswire.com:
https://www.accesswire.com/632328/Havn-Life-Sciences-to-Host-Investor-Webcast-on-March-3-2021

HAVN LIFE SCIENCES-Aktie komplett kostenlos handeln - auf Smartbroker.de
© 2021 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.